• Eur J Anaesthesiol · Apr 2021

    Intra-operative infusion of esmolol and pain following mastectomy: A randomised clinical trial.

    • Fabrício T Mendonça, Alex J Tramontini, Henrique I Miake, Luciano F Seixas, Luiz Sergio F de Carvalho, and Andrei C Sposito.
    • From the Department of Anaesthesiology, Base Hospital of the Federal District, Brasilia, DF (FTM, AJT, HIM, LFS) and Cardiology Department, State University of Campinas (Unicamp), Campinas, Sao Paulo, Brazil (LSFdC, ACS).
    • Eur J Anaesthesiol. 2021 Apr 8.

    BackgroundEsmolol is a beta-1 selective blocker that has been shown to reduce postoperative pain. Its antinociceptive effects have not been tested following mastectomy.ObjectiveTo evaluate the safety, efficacy and antinociception of intra-operative esmolol infusion after mastectomy.DesignRandomised, double-blinded, placebo-controlled trial.SettingTertiary referral centre, Brasília, Brazil. Recruitment: July 2015 to July 2017.PatientsSeventy women scheduled for mastectomy, ASA I to III, aged 18 to 75 years. Four were excluded.InterventionsAll underwent general anaesthesia. The intervention group received a bolus of 0.5 mg kg-1 of esmolol over 10 min followed by a continuous infusion of 100 μg kg-1 min-1. The placebo group received saline.Main Outcome MeasuresThe primary outcome was pain at rest 24 h after mastectomy as measured by a 0 to 10 numeric rating scale.ResultsPain scores at rest 24 h after mastectomy were lower in esmolol-treated patients compared with placebo (mean difference = -1.51, 95% confidence interval (CI), -2.36 to -0.65, P = 0.001). On arrival in the postanaesthesia care unit (PACU), the occurrence of pain was also lower in the esmolol group, at rest and on effort (P = 0.009 and P = 0.013, respectively), on discharge from PACU (P = 0.009 and P = 0.015), 12 h (P = 0.01 and P = 0.007) and on effort in the 24 postoperative hours (P = 0.003). Mean morphine consumption was reduced by 77% in the esmolol group compared with the placebo group (mean difference  = -2.52 mg, 95% CI = -3.67 to -1.38, P < 0.001). The length of hospital stay was shorter for the esmolol group (mean difference = -6.9 h, 95% CI, -13.4 to -0.31, P = 0.040).ConclusionEsmolol was well tolerated, allowed a notable reduction in the dose of rescue analgesics and demonstrated superior efficacy compared to placebo for pain management after mastectomy.Trial RegistrationClinicalTrials/NCT02466542.Copyright © 2021 European Society of Anaesthesiology.

      Pubmed     Full text   Copy Citation  

      Add institutional full text...


    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..


Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
988,657 articles already indexed!

We guarantee your privacy. Your email address will not be shared.